SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Titan Biotech Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524717 INE150C01011 189.4317315 Not Listed 0.2 833.68 40.48 24.92 10
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales54.3546.5035.17
Other Operating Income0.000.000.00
Other Income 1.320.721.38
Total Income55.6847.2236.55
Total Expenditure 45.0337.7630.60
PBIDT10.659.465.95
Interest 0.220.200.08
PBDT10.439.265.87
Depreciation1.211.150.84
Tax2.861.921.25
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.500.030.02
Reported Profit After Tax6.866.163.77
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item6.866.163.77
    
EPS (Unit Curr.)8.307.464.56
EPS (Adj) (Unit Curr.)8.307.464.56
Calculated EPS (Unit Curr.)8.307.464.56
Calculated EPS (Adj) (Unit Curr.)8.307.464.56
Calculated EPS (Ann.) (Unit Curr.)33.2229.8218.23
Calculated EPS (Adj) (Ann.) (Unit Curr.)33.2229.8218.23
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity8.268.268.26
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)19.6020.3416.92
PBDTM(%)19.1919.9116.69
PATM(%)12.6213.2510.72